1. Home
  2. POWI vs OGN Comparison

POWI vs OGN Comparison

Compare POWI & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Power Integrations Inc.

POWI

Power Integrations Inc.

HOLD

Current Price

$46.97

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.91

Market Cap

1.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POWI
OGN
Founded
1988
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.8B
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
POWI
OGN
Price
$46.97
$6.91
Analyst Decision
Strong Buy
Hold
Analyst Count
3
4
Target Price
$61.00
$11.75
AVG Volume (30 Days)
870.8K
4.2M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
1.79%
1.16%
EPS Growth
N/A
N/A
EPS
0.39
0.72
Revenue
$443,504,000.00
$6,216,000,000.00
Revenue This Year
$8.12
$0.42
Revenue Next Year
$16.54
$1.67
P/E Ratio
$123.96
$9.60
Revenue Growth
5.86
N/A
52 Week Low
$30.86
$6.18
52 Week High
$63.04
$15.88

Technical Indicators

Market Signals
Indicator
POWI
OGN
Relative Strength Index (RSI) 52.71 36.47
Support Level $44.13 $6.48
Resistance Level $49.03 $7.74
Average True Range (ATR) 2.08 0.37
MACD -0.10 -0.08
Stochastic Oscillator 35.83 23.28

Price Performance

Historical Comparison
POWI
OGN

About POWI Power Integrations Inc.

Power Integrations Inc designs, develops, and markets analog and mixed-signal integrated circuits (ICs) and other electronic components and circuitry used in high-voltage power conversion. Products are used in power converters that convert electricity from a high-voltage source to the type of power required for a specified downstream use. Products are used in electronic products including mobile phones, computing and networking equipment, appliances, electronic utility meters, battery-powered tools, industrial controls, home automation, or Internet of Things applications such as networked thermostats, power strips, and security devices. Geographically, the company generates maximum revenue from China and Hong Kong.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: